HealthcareServices

Primary Care POC Diagnostics Market Expansion Outlook: $22.88 Billion by 2029 Forecast

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Primary Care POC Diagnostics Market Between 2025 And 2029?

The primary care point-of-care diagnostics market size has experienced considerable growth recently. It is projected to increase from $16.35 billion in 2024 to $17.38 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%. This expansion in the past can be attributed to the rising incidence of chronic diseases, the transition towards personalized medicine, increasing expenditure on healthcare, the emergence of supportive regulatory frameworks along with faster approval processes, and an elevated focus on early disease identification and prevention methods.

The primary care poc diagnostics market size is anticipated to experience substantial expansion in the coming years. By 2029, its value is projected to reach $22.88 billion, demonstrating a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is propelled by factors such as the rise of infectious disease outbreaks, broader applications in non-communicable diseases, increased utilization in home healthcare environments, advancements in precision medicine, greater investments in healthcare infrastructure, an escalating disease burden, and heightened recognition of the significance of early disease detection. Key developments expected in the forecast period encompass the incorporation of artificial intelligence (AI) and machine learning algorithms, enhancements in molecular diagnostics technologies, the shrinking size and increased mobility of POC diagnostic devices, integration with smart devices, and the application of multiplexing and panel testing within POC diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

Which Factors And Drivers Are Influencing The Primary Care POC Diagnostics Market In 2025?

An increase in the occurrence of infectious diseases is anticipated to boost the expansion of the primary care POC diagnostics market in the future. These conditions are illnesses resulting from disease-causing microorganisms like bacteria, viruses, fungi, or parasites. Such diseases transmit between individuals, either directly or indirectly, via exposure to tainted surfaces, air, water, or carriers like insects. The widespread presence of infectious diseases stems from substandard environmental circumstances, increasing urbanization, resistance to antimicrobials, and insufficient vaccination rates. Primary care POC diagnostics serve as crucial instruments in combating the widespread nature of infectious diseases, enabling prompt detection, rapid treatment, and efficient disease management strategies across various healthcare environments. For example, in October 2023, a report issued by the UK Health Security Agency, a UK-based governmental body charged with supervising and managing public health security, indicated that HIV diagnoses in England saw a 22% increase, climbing from 3,118 in 2021 to 3,805 in 2022. Moreover, in November 2023, the World Health Organization (WHO), a Switzerland-based specialized UN agency overseeing international public health, reported approximately 10.6 million global tuberculosis (TB) cases in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the growing occurrence of infectious diseases is a key factor propelling the primary care POC diagnostics market.

What Are The Different Segment Classifications Within The Primary Care POC Diagnostics Market?

The primary care poc diagnosticsmarket covered in this report is segmented –

1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products

2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices

Which Market Trends Are Creating New Opportunities In The Primary Care POC Diagnostics Industry?

Leading companies in the primary care POC diagnostics market are focusing on advanced technological solutions, including portable point-of-care RT-PCR options, to enhance their market revenue. Portable point-of-care (POC) RT-PCR solutions are compact, mobile devices engineered to perform real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside of traditional laboratory settings. For example, in October 2022, Genes2Me Pvt. Ltd., an India-based manufacturer of molecular diagnostic solutions, launched the Rapi-Q Point of Care RT PCR solution designed for conditions such as HPV and tuberculosis. This solution features an eight-well block design with four fluorescent channels, is described as user-friendly, and can deliver faster results in less than 45 minutes. The Rapi-Q system is portable and lightweight, making it suitable for use in hospitals, blood banks, health clinics, research laboratories, and airports. The solution offers high sensitivity, accuracy, and performance in detecting a variety of diseases and is compatible with over 50 lyophilized, room-temperature disease detection kits.

Which Major Firms Are Strengthening Their Position In The Primary Care POC Diagnostics Industry?

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

How Is Primary Care POC Diagnostics Market Demand Varying Across Different Regions?

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Primary Care POC Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2025, By The Business Research Company

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795